Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update – IT Business Net itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO trial of tebipenem HBr; Trial expected to begin with First Patient, First Visit in 4Q 2023 Conference call and webcast at 4:30pm ET.
'Wander and wonder': How to navigate your first ACR Convergence healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
The meeting will focus on new research and debate the latest results and foster collaboration to accelerate progress in the treatment of treatment of bronchiectasis and NTM infections.